Finder is committed to editorial independence. While we receive compensation when you click links to partners, they do not influence our content.
How to buy Edesa Biotech (EDSA) stocks in Canada
Learn how to easily invest in Edesa Biotech stocks.
Edesa Biotech is a biotechnology business based in the US. Edesa Biotech stocks (EDSA.US) are listed on the NASDAQ and all prices are listed in US Dollars. Its last market close was $5.17 – an increase of 2.16% over the previous week. Edesa Biotech employs 16 staff and has a trailing 12-month revenue of around $500.
How to buy stocks in Edesa Biotech
- Compare stock trading platforms. Use our comparison table to help you find a platform that fits you.
- Open your brokerage account. Complete an application with your details.
- Confirm your payment details. Fund your account.
- Research the stock. Find the stock by name or ticker symbol – EDSA – and research it before deciding if it's a good investment for you.
- Purchase now or later. Buy your desired number of stocks with a market order or use a limit order to delay your purchase until the stock reaches a desired price.
- Check in on your investment. Optimize your portfolio by tracking your stock.
What's in this guide?
- Can I buy shares in Edesa Biotech?
- Has coronavirus impacted Edesa Biotech shares?
- Edesa Biotech shares summary
- Compare share dealing platforms
- Is Edesa Biotech stock a buy or sell?
- Edesa Biotech performance over time
- Edesa Biotech's financials
- How volatile are Edesa Biotech shares?
- Does Edesa Biotech pay a dividend?
- Have Edesa Biotech shares ever split?
- Other common questions
Edesa Biotech stock price (NASDAQ:EDSA)Use our graph to track the performance of EDSA stocks over time.
Edesa Biotech shares at a glance
|Latest market close||$1.89|
|52-week range||$1.72 - $12.00|
|50-day moving average||$2.67|
|200-day moving average||$5.00|
|Wall St. target price||$18.00|
|Dividend yield||$0 (0%)|
|Earnings per share (TTM)||$-1.12|
Compare stock trading platforms
Note: The dollar amounts in the table below are in Canadian dollars.
Is it a good time to buy Edesa Biotech stock?
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
Edesa Biotech price performance over time
|1 week (2022-05-12)||3.28%|
|1 month (2022-04-21)||-28.41%|
|3 months (2022-02-17)||N/A|
|6 months (2021-11-19)||-71.66%|
|1 year (2021-05-21)||-71.75%|
|2 years (2020-05-21)||-34.83%|
|3 years (2019-05-21)||85.29%|
|5 years (2017-05-19)||48.82%|
Edesa Biotech financials
|Gross profit TTM||$311,200|
|Return on assets TTM||-144.86%|
|Return on equity TTM||-152.31%|
|Market capitalisation||$29.5 million|
TTM: trailing 12 months
Edesa Biotech share dividends
We're not expecting Edesa Biotech to pay a dividend over the next 12 months.
Have Edesa Biotech's shares ever split?
Edesa Biotech's shares were split on a 1:6 basis on 10 June 2019. So if you had owned 6 shares the day before before the split, the next day you'd have owned 1 share. This wouldn't directly have changed the overall worth of your Edesa Biotech shares – just the quantity. However, indirectly, the new 500% higher share price could have impacted the market appetite for Edesa Biotech shares which in turn could have impacted Edesa Biotech's share price.
Edesa Biotech share price volatility
Over the last 12 months, Edesa Biotech's shares have ranged in value from as little as $1.72 up to $12. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Edesa Biotech's is 1.3932. This would suggest that Edesa Biotech's shares are more volatile than the average for this exchange and represent, relatively-speaking, a higher risk (but potentially also market-beating returns).
Edesa Biotech overview
Edesa Biotech, Inc. , a biopharmaceutical company, engages in acquiring, developing, and commercializing clinical-stage drugs for inflammatory and immune-related diseases with clear unmet medical needs. Its lead product candidates are EB05, a monoclonal antibody, which is in Phase 3 clinical study for the treatment of acute respiratory distress syndrome in covid-19 patients; and EB01, a topical treatment that is in Phase 2B clinical study for chronic allergic contact dermatitis. It has a license agreement with NovImmune SA to develop monoclonal antibodies targeting TLR4 and CXCL10. Edesa Biotech, Inc. was founded in 2015 and is headquartered in Markham, Canada. .
Stocks similar to Edesa Biotech
Edesa Biotech in the news
EDESA BIOTECH, INC. : Submission of Matters to a Vote of Security Holders (form 8-K)
Edesa Biotech to Present at H.C. Wainwright Global Investment Conference
EDSA: Enrollment of Phase 2b Trial of EB01 to Complete in 4Q22…
Frequently asked questions
Disclaimer: This information should not be interpreted as an endorsement of futures, stocks, ETFs, options or any specific provider, service or offering. It should not be relied upon as investment advice or construed as providing recommendations of any kind. Futures, stocks, ETFs and options trading involves substantial risk of loss and therefore are not appropriate for all investors. Trading forex on leverage comes with a higher risk of losing money rapidly. Past performance is not an indication of future results. Consider your own circumstances, and obtain your own advice, before making any trades.
More on investing
iGaming is now legal in Ontario. Find out which companies to keep an eye on with our list of 10 top online gaming stocks.Read more…
Enjoy perks like free trades and cash rewards when you open a stock trading account with these online brokers.Read more…
Here’s what you need to know about investing in the propane industry, including 3 popular propane stocks to watch.Read more…
More guides on Finder
Apps like Wealthsimple
Learn more about apps like Wealthsimple to find the best trading platform for your unique set of needs.
Online gaming stocks
iGaming is now legal in Ontario. Find out which companies to keep an eye on with our list of 10 top online gaming stocks.
How to buy Entain stock in Canada
Steps to owning and managing ENT stock, with 24-hour and historical pricing before you buy.
How to buy Kambi Group stock in Canada
Steps to owning and managing KAMBI stock, with 24-hour and historical pricing before you buy.
Best brokerage signup bonuses in 2022
Enjoy perks like free trades and cash rewards when you open a stock trading account with these online brokers.
How to buy Rush Street Interactive stock in Canada
Steps to owning and managing RSI stock, with 24-hour and historical pricing before you buy.
How to buy PointsBet stock in Canada
Steps to owning and managing PBTHF stock, with 24-hour and historical pricing before you buy.
How to buy Hanover Bancorp, Inc. (HNVR) stock in Canada when it goes public
Everything we know about the Hanover Bancorp, Inc. IPO, plus information on how to buy in.
How to buy PrimeBlock stock in Canada when it goes public
Everything we know about the PrimeBlock IPO, plus information on how to buy in.
How to buy Actelis Networks (ASNS) stock in Canada when it goes public
Everything we know about the Actelis Networks IPO, plus information on how to buy in.